Your Cart ( 3 Items )

  • Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial
    August 2016 | Volume 15 | Issue 8 | Original Article | 931 | Copyright © August 2016
    Michael David MD,a Dimitar Konstantinov Gospodinov MD,b Nicola Gheorghe MD,c Grisha Stefanov Mateev MD,d Mariyana Venelinova Rusinova MD,e Evgeniya Hristakieva MD,f Laura Gheuca Solovastru MD,g Rita.V. Patel MD,h Calin Giurcaneanu MD,i Mariela Chepileva Hitova MD,j Anca Ioana Purcaru MD,j Beti Horia MD,k Iliya Iliev Tsingov MD,l Rumyana Kaloferova Yankova MD,m Miroslava Ilieva Kadurina MD,n Michal Ramon MD,o Maria Rotaru MD,p Olga Simionescu MD,q Vasile Benea MD,r Zdravka Velichkova Demerdjieva MD,s Maria Rodica Cosgarea MD,t Horia Silviu Morariu MD,u Ziv Michael MD,v Patricia Cristodor MD,w Carmen Nica MD,x Michael H. Silverman MD,y David R. Bristol PhD,y Zivit Harpaz MSc,y Motti Farbstein BSc,y Shira Cohen MSc,y and Pnina Fishman PhDy
    You will have 48 hours to download the full-text PDF

    Price

    24.95

    Term

    48 Hrs
  • Successful Desensitization to Brentuximab Vedotin After Hypersensitivity Reaction
    June 2014 | Volume 13 | Issue 6 | Case Reports | 749 | Copyright © June 2014
    Sara K. Story MD,a Andrej A. Petrov MD,b and Larisa J. Geskin MD FAADa
    You will have 48 hours to download the full-text PDF

    Price

    24.95

    Term

    48 Hrs
  • The Efficacy and Safety of Tavaborole, a Novel, Boron-Based Pharmaceutical Agent: Phase 2 Studies Conducted for the Topical Treatment of Toenail Onychomycosis
    September 2014 | Volume 13 | Issue 9 | Original Article | 1124 | Copyright © September 2014
    Mirna E. Toledo-Bahena MD,a Alicia Bucko DO JD,b Jorge Ocampo-Candiani MD,c Maira E. Herz-Ruelas MD,c
    Terry M. Jones MD,d Michael T. Jarratt MD,e Richard A. Pollak DPM MS,f Lee T. Zane MDg
    You will have 48 hours to download the full-text PDF

    Price

    24.95

    Term

    48 Hrs
Total ( 3 Items ) $74.85 CHECKOUT